What's Happening?
Solace Health, a patient advocacy platform, has announced the expansion of its care navigation services to include most major health plans, such as UnitedHealthcare and Anthem Blue Cross Blue Shield. Previously, Solace's services were primarily available
to Medicare and Medicare Advantage patients. This expansion allows many commercially insured patients to access Solace's services, although specific commercial plans were not detailed in the announcement. Solace pairs each patient with a dedicated healthcare advocate to assist with navigating the complex healthcare system, which includes coordinating care, managing records, and resolving billing issues. The company was founded in 2022 by CEO Jeremy Gurewitz and Chief Product Officer Sara Sargent, inspired by Gurewitz's personal experience with his mother's cancer diagnosis. Solace claims that 98% of patients feel more in control and 92% experience better health outcomes after working with their advocates, based on a 2023 report by the Coalition of Healthcare Advocacy Organizations.
Why It's Important?
The expansion of Solace Health's services to commercially insured patients is significant as it addresses a critical gap in healthcare navigation. With over 60% of U.S. adults demonstrating inadequate health literacy, according to a 2025 study, the need for professional assistance in managing healthcare is evident. By providing dedicated advocates, Solace aims to alleviate the administrative and emotional burdens on patients, particularly during times when they are least equipped to handle them. This move could potentially improve health outcomes for millions of Americans by ensuring they receive timely and coordinated care. Additionally, the expansion reflects a growing trend in the healthcare industry towards personalized and patient-centered services, which could influence other healthcare providers to adopt similar models.
What's Next?
Following the expansion, Solace Health plans to continue growing its national advocate network, supported by a recent $130 million Series C funding round. This funding, which valued the company at $1 billion, will be used to enhance their services and reach more patients. As of February, Solace had 2,000 advocates serving over 20,000 patients monthly. The company is likely to focus on further integrating its services with additional commercial health plans and expanding its reach to more patients across the U.S. The success of this expansion could prompt other healthcare advocacy platforms to explore similar partnerships with commercial insurers, potentially reshaping the landscape of patient care navigation.
